SI1560827T1 - Anti-infective agents - Google Patents

Anti-infective agents

Info

Publication number
SI1560827T1
SI1560827T1 SI200331953T SI200331953T SI1560827T1 SI 1560827 T1 SI1560827 T1 SI 1560827T1 SI 200331953 T SI200331953 T SI 200331953T SI 200331953 T SI200331953 T SI 200331953T SI 1560827 T1 SI1560827 T1 SI 1560827T1
Authority
SI
Slovenia
Prior art keywords
compound
hcv
inhibiting
processes
polymerase
Prior art date
Application number
SI200331953T
Other languages
Slovenian (sl)
Inventor
John K Pratt
David A Betebenner
Pamela L Donner
Brian E Green
Dale J Kempf
Keith F Mcdaniel
Clarence J Maring
Vincent S Stoll
Rong Zhang
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/285,714 external-priority patent/US20040097492A1/en
Priority claimed from US10/625,121 external-priority patent/US20040162285A1/en
Priority claimed from US10/679,881 external-priority patent/US20050075331A1/en
Application filed by Abbott Lab filed Critical Abbott Lab
Priority claimed from EP03768559A external-priority patent/EP1560827B1/en
Publication of SI1560827T1 publication Critical patent/SI1560827T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide an HCV (hepatitis C virus) polymerase inhibiting compound and a composition including a therapeutically effective amount of the compound. <P>SOLUTION: This invention relates to the compound having formula (I). This invention also relates to methods for inhibiting HCV polymerase, inhibiting HCV viral replication, and treating or preventing HCV infection. Processes for making the compounds and the synthetic intermediates employed in the processes, are also provided. <P>COPYRIGHT: (C)2011,JPO&INPIT
SI200331953T 2002-11-01 2003-10-31 Anti-infective agents SI1560827T1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US10/285,714 US20040097492A1 (en) 2002-11-01 2002-11-01 Anti-infective agents
US10/410,853 US20040087577A1 (en) 2002-11-01 2003-04-10 Anti-infective agents
US10/625,121 US20040162285A1 (en) 2002-11-01 2003-07-23 Anti-infective agents
US10/679,881 US20050075331A1 (en) 2003-10-06 2003-10-06 Anti-infective agents
EP03768559A EP1560827B1 (en) 2002-11-01 2003-10-31 Anti-infective agents
PCT/US2003/034707 WO2004041818A1 (en) 2002-11-01 2003-10-31 Anti-infective agents

Publications (1)

Publication Number Publication Date
SI1560827T1 true SI1560827T1 (en) 2011-04-29

Family

ID=43426110

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200331953T SI1560827T1 (en) 2002-11-01 2003-10-31 Anti-infective agents

Country Status (6)

Country Link
JP (2) JP4738172B2 (en)
AT (1) ATE493408T1 (en)
DE (1) DE60335564D1 (en)
DK (1) DK1560827T3 (en)
PT (1) PT1560827E (en)
SI (1) SI1560827T1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA100120C2 (en) 2007-04-03 2012-11-26 Анадис Фармасьютикалз, Инк. 5,6-dihydro-1h-pyridin-2-one compounds
GB0800855D0 (en) * 2008-01-17 2008-02-27 Syngenta Ltd Herbicidal compounds
AU2009241514A1 (en) * 2008-04-15 2009-11-05 Intermune, Inc. Novel inhibitors of hepatitis C virus replication
EA201100661A1 (en) * 2008-10-29 2011-12-30 Басф Се SUBSTITUTED PYRIDINS WITH HERBICIDAL ACTION
MX2011008641A (en) * 2009-03-06 2011-09-06 Hoffmann La Roche Heterocyclic antiviral compounds.
JP2013525368A (en) * 2010-04-23 2013-06-20 キネタ・インコーポレイテツド Antiviral compounds
SG195288A1 (en) * 2011-06-07 2013-12-30 Anadys Pharmaceuticals Inc [1,2,4]thiadiazine 1,1-dioxide compounds for lowering serum uric acid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001085172A1 (en) * 2000-05-10 2001-11-15 Smithkline Beecham Corporation Novel anti-infectives
AR036081A1 (en) * 2001-06-07 2004-08-11 Smithkline Beecham Corp COMPOSITE OF 1,2-DIHYDROQUINOLINE, ITS USE TO PREPARE A PHARMACEUTICAL COMPOSITION, METHODS TO PREPARE IT AND N-RENTED 2-AMINOBENZOIC ACID OF UTILITY AS INTERMEDIARY IN SUCH METHODS
WO2003059356A2 (en) * 2001-10-30 2003-07-24 Smithkline Beecham Corporation Novel anti-infectives

Also Published As

Publication number Publication date
JP2011144183A (en) 2011-07-28
JP4738172B2 (en) 2011-08-03
JP5250649B2 (en) 2013-07-31
JP2006509042A (en) 2006-03-16
ATE493408T1 (en) 2011-01-15
PT1560827E (en) 2011-03-17
DE60335564D1 (en) 2011-02-10
DK1560827T3 (en) 2011-04-18

Similar Documents

Publication Publication Date Title
EP2361913A8 (en) Anti-infective agents
WO2007076034A3 (en) Anti-viral compounds
WO2007081517A8 (en) Anti-viral compounds
WO2007076035A3 (en) Anti-viral compounds
AP1782A (en) Use of compounds ?-D or ?-L nucleoside for treating hepatitis C virus.
BR0305259A (en) Hcv ns5b polymerase inhibitors
BR0309581A (en) Nucleoside derivatives for treatment of hepatitis c virus infection
WO2004009020A3 (en) Pyrrolopyrimidine thionucleoside analogs as antivirals
EE05709B1 (en) The nucleoside compound, the pharmaceutical composition containing it and its use in the manufacture of a medicament for use as a viral RNA-dependent RNA polymerase inhibitor
MY140680A (en) Hepatitis c virus inhibitors
EA200900156A1 (en) Pyridazine compound (VARIANTS), METHOD FOR ITS PREPARATION (VARIANTS), METHOD FOR TREATMENT OR PREVENTION OF VIRAL INFECTION WITH HEPATITIS C USING IT, compositions and medicaments based on its
TW200518746A (en) Novel inhibitors of hepatitis C virus NS3/NS4A serine protease
WO2005054430A3 (en) Hepatitis c virus inhibitors
HK1100164A1 (en) Macrocyclic carboxylic acid and acylsulfonamide compound as inhibitor of hcv replication
ATE522528T1 (en) VIRAL INHIBITORS
IS8448A (en) Hepatitis C virus inhibition
WO2008057871A3 (en) Inhibitors of hepatitis c virus
WO2004043339A3 (en) Substituted cycloalkyl p1&#39; hepatitis c virus inhibitors
WO2008057875A3 (en) Inhibitors of hepatitis c virus
BR0110023A (en) Substituted 3&#39;-or-2 &#39;nucleoside derivatives for treatment of hepatitis virus infections
WO2008057873A3 (en) Inhibitors of hepatitis c virus
SI1719773T1 (en) Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor
BR0115447A (en) Hepatitis C Tripeptide Inhibitors
BRPI0515596A (en) pharmaceutical composition used for the treatment and / or prevention of hcv, and methods of inhibiting hepatitis c polymerase ns5b from treating or preventing hepatitis c infection in a mammal
SI1560827T1 (en) Anti-infective agents